Drug Discovery · Boston, MA · Founded 2017 · Privately Held (backing)
Developer of a medicine infrastructure platform intended to create medicines that respond to disease signals in real-time. Strand Therapeutics is based in Boston, MA and was founded in 2017. It was valued at $571 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $256 million across 3 recorded rounds; the latest was a $153 million Series B in Aug 2025.
PMV mark · valuation
$571.0M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$255.6M
Last round
Later Stage VC (Series B)
Aug 2025
Cap table — not yet on record
Strand Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Strand Therapeutics with a free account
·The complete investor list: 30 names
·Watch Strand Therapeutics: the Monday email on marks, rounds and moves
Where does Strand Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Strand Therapeutics's 3 recorded funding rounds.
